Thus, PTPN13 may suppress oncogenic Src signalling [106], whilst the loss of PTPN13 expression [107] or germ-line mutations in PTPN13 [108] have been described in NSCLC and acute lymphoblastic leukaemia, respectively. This evidence concerns the gene PTPN13 and acute lymphoblastic leukemia.